Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’
We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In ...
CNBC on MSN12d
Merck CEO talks medicines beyond the company's top cancer drug
Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than its lucrative cancer drug, ...
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...
9 Stocks on Jim Cramer’s Radar
Jim Cramer, host of Mad Money, recently emphasized the importance of long-term investing, urging investors to focus on the ...
TheStreet.com5y
Two Pharmaceutical Stocks That Jim Cramer's Watching
The reason Cramer's got Merck on the mind? Well, it's simple, really. The drug pricing debate is circulating around cancer drugs, which is something that Merck has a focus on. Here's what ...
Jim Cramer on Eli Lilly and Company (LLY)’s Q4 2024 Performance: ‘Aren’t As Strong As Wall Street Was Hoping’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...
NBC New York12d
Merck CEO talks medicines beyond the company's top cancer drug
Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than its lucrative cancer drug, Keytruda, and he described other ventures in its portfolio. "Keytruda has ...